You may experience a slight disruption in services
ESMO Breast 2020: will you be among the contributors to the latest data in breast cancer? Submit your abstract by 4 February 2020
The latest standards in the field. Register by 20 November 2019 to discover them
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
Our journals offer ESMO members and the oncology community a globally visible platform to publish scientific studies, and a highly credible source of educational updates.
The ESMO-MCBS scale is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Olivier Michielin comments on two studies presented at ESMO 2019 providing new insights into the use of liquid biopsy in early detection.
21 Oct 2019
ESMO Members: watch our webinar chaired by Anthony TC Chan and gain unique insights in this area
21 Oct 2019
New indication concerns its combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma
18 Oct 2019
New indication concerns mono or combination with chemotherapy in the first-line treatment of metastatic or unresectable recurrent HNSCC
17 Oct 2019
A programme of research into social outcomes after AYA cancer and its treatment
15 Oct 2019
ESMO would like to thank the National Oncology Institute with its office at the National Cancer Institute in Bratislava for providing translation in...
14 Oct 2019
ESMO would like to thank the organisation BISER for providing translation into Serbian
Barcelona, Spain
21 Oct
- 22 Oct
2019
Valencia, Spain
25 Oct
- 26 Oct
2019
London, United Kingdom
07 Nov
- 09 Nov
2019
Vienna, Austria
14 Nov
- 17 Nov
2019
Singapore
20 Nov
- 21 Nov
2019
Singapore, Singapore
22 Nov
- 24 Nov
2019
